quinoxalines has been researched along with oxiracetam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kessler, M; Lynch, G; Staubli, U; Xiao, P | 1 |
| Lu, Y; Wehner, JM | 1 |
2 other study(ies) available for quinoxalines and oxiracetam
| Article | Year |
|---|---|
Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus.
Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Hippocampus; Hydroxybenzoate Ethers; Hydroxybenzoates; Long-Term Potentiation; Pyrrolidines; Pyrrolidinones; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Structure-Activity Relationship; Synaptic Transmission | 1991 |
Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.
Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Benzodiazepines; Conditioning, Classical; Cues; Excitatory Amino Acid Antagonists; Fear; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nootropic Agents; Pyrrolidines; Pyrrolidinones; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 1997 |